Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...

The same year, Novartis acquired the North American over-the-counter brand portfolio of Bristol-Myers Squibb. In 2006, Novartis announced the creation of a biomedical R&D centre in Shangai, China.

Bristol Myers Squibb Presents Late-Breaking Data from Pivotal Phase 3 POETYK PsA-1 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis ...

Investors have been keeping a sharp eye on Bristol Myers as its stock has lagged behind peers recently. Bristol Myers’ stock ...

See the latest Bristol-Myers Squibb Co stock price (BMY:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Check out the latest Bristol Myers Squibb Co. (BMY) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

Access to and affordability of immune checkpoint inhibitors, which can be lifesaving if patients receive them on time and ...

Bristol-Myers Squibb Company (BMY) dividend yield: annual payout, 4 year average yield, yield chart and 10 year yield history.

Bristol-Myers Squibb announced promising progress on its Phase 2 Alzheimer’s clinical trial of BMS-986446, an experimental ...